These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In vivo assessment of a novel dacron surface with covalently bound recombinant hirudin. Wyers MC; Phaneuf MD; Rzucidlo EM; Contreras MA; LoGerfo FW; Quist WC Cardiovasc Pathol; 1999; 8(3):153-9. PubMed ID: 10722238 [TBL] [Abstract][Full Text] [Related]
8. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides. Nihalani D; Raghava GP; Sahni G Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel hirudin-coated polyester graft to physiologic flow conditions: hirudin bioavailability and thrombin uptake. Berceli SA; Phaneuf MD; LoGerfo FW J Vasc Surg; 1998 Jun; 27(6):1117-27. PubMed ID: 9652474 [TBL] [Abstract][Full Text] [Related]
10. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin. Krstenansky JL; Broersma RJ; Owen TJ; Payne MH; Yates MT; Mao SJ Thromb Haemost; 1990 Apr; 63(2):208-14. PubMed ID: 2363122 [TBL] [Abstract][Full Text] [Related]
11. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442 [TBL] [Abstract][Full Text] [Related]
12. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae. Lehman ED; Joyce JG; Bailey FJ; Markus HZ; Schultz LD; Dunwiddie CT; Jacobson MA; Miller WJ Protein Expr Purif; 1993 Jun; 4(3):247-55. PubMed ID: 8518563 [TBL] [Abstract][Full Text] [Related]
13. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study. Szemraj J; Walkowiak B; Kawecka I; Janiszewska G; Buczko W; Bartkowiak J; Chabielska E J Thromb Haemost; 2005 Oct; 3(10):2156-65. PubMed ID: 16150047 [TBL] [Abstract][Full Text] [Related]
14. A fusion protein with improved thrombolytic effect and low bleeding risk. Wang X; Zhang G; Wang L; Zhang Q; Qin Y; Wu C; Yu A Thromb Haemost; 2009 Dec; 102(6):1194-203. PubMed ID: 19967151 [TBL] [Abstract][Full Text] [Related]
15. Interaction of immobilized human plasminogen and plasmin with streptokinase. Shi GY; Chang BI; Wu DH; Wu HL Biochem Biophys Res Commun; 1993 Aug; 195(1):192-200. PubMed ID: 8363600 [TBL] [Abstract][Full Text] [Related]
16. Mutation of lysines in a plasminogen binding region of streptokinase identifies residues important for generating a functional activator complex. Lin LF; Oeun S; Houng A; Reed GL Biochemistry; 1996 Dec; 35(51):16879-85. PubMed ID: 8988027 [TBL] [Abstract][Full Text] [Related]
17. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom. Sanchez EF; Santos CI; Magalhaes A; Diniz CR; Figueiredo S; Gilroy J; Richardson M Arch Biochem Biophys; 2000 Jun; 378(1):131-41. PubMed ID: 10871053 [TBL] [Abstract][Full Text] [Related]
18. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo. Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of thrombin by hirudin genetically fused to wild-type or mutant antithrombin. Syed S; Kelly KE; Sheffield WP Thromb Res; 1996 Dec; 84(6):419-29. PubMed ID: 8987163 [TBL] [Abstract][Full Text] [Related]